[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611616":3},{"organization":4,"outcomesModule":7,"designInfo":24,"detailedDescription":32,"studyPopulation":29,"armGroups":33,"interventions":40,"overallOfficials":45,"centralContacts":49,"locations":29,"responsibleParty":54,"collaborators":29,"id":56,"slug":29,"hasResults":57,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":29,"eligibilityCriteria":61,"healthyVolunteers":57,"sex":62,"minAge":63,"maxAge":64,"enrollmentInfo":65,"targetDuration":29,"studyType":68,"phases":69,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":78,"whyStopped":29,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":29},{"fullName":5,"class":6},"Artvin Coruh University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":15,"otherOutcomes":20},[9,13],{"measure":10,"description":11,"timeFrame":12},"Dysfunctional Voiding and Incontinence Symptom Score (DVISS)","DVISS includes 14 items: 13 assess lower urinary tract symptoms (LUTS), voiding and defecation habits day and night, and one evaluates impact on severity and daily life activities (DLA). A score of 8.5+ indicates abnormal voiding; higher scores mean more severe disease.","Baseline",{"measure":10,"description":11,"timeFrame":14},"At Week 8, immediately after completion of the 8-week intervention",[16,19],{"measure":17,"description":18,"timeFrame":12},"Pediatric Urinary Incontinence Quality of Life Questionnaire (PIN-Q)","This 4-point Likert scale assesses the emotional impact of UI on a child, with 20 questions and a maximum score of 80. Higher scores mean a greater impact on QoL: 0-20 is mild, 21-50 moderate, and 51+ severe.",{"measure":17,"description":18,"timeFrame":14},[21],{"measure":22,"description":23,"timeFrame":14},"Global Rating Change (GRC)","The GRC comprised seven responses, ranging from 1 to 5, indicating \"very much better,\" \"slightly better,\" \"no change,\" \"slightly worse,\" and \"very much worse,\" respectively.",{"allocation":25,"interventionModel":26,"interventionModelDescription":27,"primaryPurpose":28,"observationalModel":29,"timePerspective":29,"maskingInfo":30},"NA","SINGLE_GROUP","In this prospective study, one treatment group was formed to receive SU.","TREATMENT",null,{"masking":31,"maskingDescription":29,"whoMasked":29},"NONE","100 children with UI will receive standard urotherapy (SU) for 8 weeks. UI-related symptoms and quality of life (QoL) will be assessed with the DVISS and PIN-Q baseline and after treatment. The receiver operating characteristic (ROC) analysis and the Gamma coefficient will be employed to assess responsiveness.",[34],{"label":35,"type":36,"description":37,"interventionNames":38},"Standard urotherapy (SU)","EXPERIMENTAL","Children with UI will receive SU as previously recommended.",[39],"Other: Standard Urotherapy (SU)",[41],{"type":6,"name":42,"description":43,"armGroupLabels":44,"otherNames":29},"Standard Urotherapy (SU)","SU will be included appropriate provision of information and demystification, lifestyle advice, instructions, behavioral modifications to achieve optimal bladder and bowel habits, registration of symptoms and voiding habits, support, and encouragement",[35],[46],{"name":47,"affiliation":5,"role":48},"Zeynep Yıldız Kızkın","PRINCIPAL_INVESTIGATOR",[50],{"name":47,"role":51,"phone":52,"phoneExt":29,"email":53},"CONTACT","+905346945085","pt.zeynepyildiz@gmail.com",{"type":48,"investigatorFullName":47,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":29,"oldOrganization":29},"Lecturer","100611616",false,"NCT07242898","Clinically Important or Just Statistically Significant? MCID for DVISS and PIN-Q in Children With UI","Clinically Important or Just Statistically Significant? Minimal Clinically Important Difference for DVISS and PIN-Q in Children With Urinary Incontinence","Inclusion Criteria:\n\n* diagnosis of UI according to the International Children's Continence Society (ICCS) Guideline,\n* children aged 5-13 years (when UI becomes more prevalent in children).\n\nExclusion Criteria:\n\n* congenital anomalies of the uro-genital system,\n* only neurogenic bladder dysfunction.","ALL","5 Years","13 Years",{"count":66,"type":67},100,"ESTIMATED","INTERVENTIONAL",[25],"The goal of this study was to determine the Minimal Clinically Important Difference (MCID) for the Dysfunctional Voiding and Incontinence Symptom Score (DVISS) and the Pediatric Incontinence Questionnaire (PIN-Q) in children with urinary incontinence (UI).",[72],"Urinary Incontinence",[74,75,76,77],"minimal clinically important difference","urinary incontinence","quality of life","ROC curve","NOT_YET_RECRUITING","2025-11-19",{"date":81,"type":82},"2025-11-21","ACTUAL",{"date":84,"type":67},"2026-09-01",{"date":86,"type":67},"2026-12-01",{"name":5,"class":6}]